Timeline

01 Jan 2023
publication

Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma.

Read more
07 Mar 2022
publication

The Sec61 translocon is a therapeutic vulnerability in multiple myeloma.

Read more
11 Jan 2022
news

New publication – The Sec61 translocon is a therapeutic vulnerability in multiple myeloma

Read more